Methods for treatment of cancer with an Anti-tigit antagonist antibody

TW202639166APending Publication Date: 2026-10-01GENENTECH INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149384
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-17
Filing Date
2021-01-26
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078822_001
    Figure TWG2TA001078822_001
  • Figure TWG2TA001078822_002
    Figure TWG2TA001078822_002
  • Figure TWG2TA001078822_003
    Figure TWG2TA001078822_003
Patent Text Reader

Abstract

The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.
Need to check novelty before this filing date? Find Prior Art